NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced that Roche has selected Medidata Rave® as its enterprise-wide electronic data capture (EDC) solution. Designed to more efficiently capture and manage data collection, Medidata Rave will enable global access of clinical trial data to all relevant Roche stakeholders, while also enhancing the company’s overall drug development process.

Headquartered in Basel, Switzerland, Roche is one of the world’s leading global health care companies, focusing on providing medicines and diagnostic tools for devastating diseases worldwide. Roche will deploy Medidata Rave in clinical trials as its core enterprise-wide EDC system in a phased, multi-year approach across its five disease biology areas (oncology, inflammation, virology, metabolism and central nervous system), beginning with data collection for early stage, exploratory trials and ultimately encompassing all phases of development, through registration.

Medidata Rave has become a leader in solutions for the capture, management and reporting of clinical data on the basis of its usability, flexibility, scalability and accessibility. Data managers, investigators, monitors and other clinical team members use Rave to work collaboratively through its Web-based, easy-to-learn, easy-to-use interfaces. Rave’s robust data management tools built directly into the EDC system broaden capabilities, such as management of mid-study changes, and provide a single platform that facilitates broad, global efficiencies across multiple trials, multiple languages and multiple development programs.

“Roche’s enterprise-level investment in Medidata Rave as the foundation of its global drug development process is further proof that sponsors are looking for EDC solutions that not only offer access to data that will drive critical clinical research decisions across all phases, but also provide key efficiencies for all members of the research team,” said Tarek Sherif, CEO, Medidata Solutions. “We are proud that Medidata Rave will be playing a key role in Roche’s strategy to provide treatments and diagnostic tools that enable improvements in the health, quality of life and survival of patients worldwide.”

For more information on Medidata Rave visit: http://www.mdsol.com/products/rave_overview.htm

About Medidata Solutions Worldwide

Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer™), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.